- Ertapenem (Catalog No# : 19318, Cas# : 153832-46-3) Ertapenem is a parenteral carbapenem that is highly resistant to inactivation by a wide variety of beta-lactamases and that has a broad spectrum of antimicrobial activity.
- Eprosartan (Catalog No# : 192182, Cas# : 133040-01-4) Eprosartan is a competitive and reversible angiotensin II receptor antagonist used for the treatment of high blood pressure.
- EX-229 free acid (Catalog No# : 192153, Cas# : 1219739-36-2) EX-229, also known as AMPK Activator 991, is a novel AMPK activator, increasing AMPK activity of both AMPKgamma1- and AMPKgamma3-containing complexes in mouse skeletal muscle.
- E7046 (Catalog No# : 191101, Cas# : 1369489-71-3) E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4.
- Elacridar HCl (Catalog No# : 19121, Cas# : 143851-98-3) Elacridar, also known as GF120918A, is a P-glycoprotein (P-gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate t
- E7820 (Catalog No# : 1812293, Cas# : 289483-69-8) E7820 is a small molecule and aromatic sulfonamide derivative with potential antiangiogenic and antitumor activities.
- EMD638683 (Catalog No# : 1810253, Cas# : 1181770-72-8) EMD638683 is a potent inhibitor of SGK1 with an IC50 value of 3 μM.
- E2012 (Catalog No# : 1810231, Cas# : 870843-42-8) E2012 is a γ-secretase modulator (GSM).
- EBI-2511 (Catalog No# : 1810165, Cas# : 2098546-05-3) EBI-2511 is a Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin’s Lymphoma.
- Entasobulin (Catalog No# : 186293, Cas# : 501921-61-5) Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity.
- Epothilone D (Catalog No# : 186292, Cas# : 189453-10-9) Epothilone D is a natural polyketide compound isolated from the myxobacterium Sorangium cellulosum.
- EZM2302 (Catalog No# : 186272, Cas# : 1628830-21-6) EZM2302 is a potent, selective, and orally available arginine methyltransferase CARM1 inhibitor.
- Exatecan mesylate (Catalog No# : 186271, Cas# : 169869-90-3) Exatecan, also known as DX 8951, is semisynthetic, water-soluble camptothecin derivative with antineoplastic activity.
- Efinaconazole (Catalog No# : 186213, Cas# : 164650-44-6) Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis.
- Erteberel (Catalog No# : 186157, Cas# : 533884-09-2) Erteberel, also known as LY500307, is a selective estrogen receptor beta (ERβ) agonist that was developed for the treatment of benign prostatic hyperplasia.
- Edonerpic maleate (Catalog No# : 18671, Cas# : 519187-97-4) Edonerpic, also known as T-817, is a neuroprotectant.
- Evobrutinib (Catalog No# : 18543, Cas# : 1415823-73-2) Evobrutinib, also known as M-2951 and MSC-2364447C, is a highly selective inhibitor of the Bruton’s tyrosine kinase (BTK).
- Endoxifen E-isomer HCl (Catalog No# : 184124, Cas# : 1197194-61-8) Endoxifen E-isomer is a tamoxifen metabolite and potent Selective Estrogen Response Modifier (SERM).
- Ensartinib (Catalog No# : 184321, Cas# : 1370651-20-9) Ensartinib, also known as X-396, is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic ac
- eCF506 (Catalog No# : 18382, Cas# : 1914078-41-3) eCF506 targets a molecule called Src tyrosine kinase that is required for breast cancer cells to grow and spread. eCF506 may be highly effective at blocking growth of breast canc
- Etifoxine HCl (Catalog No# : 1712142, Cas# : 56776-32-0) Etifoxine, also known as HOE 36801 and etafenoxine, is an anxiolytic and anticonvulsant drug developed by Hoechst in the 1960s.
- Esaxerenone (Catalog No# : 1710121, Cas# : 1632006-28-0) Esaxerenone (INN) (developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and is now under development by Daiichi Sank
- EBE-A22 (Catalog No# : 179831, Cas# : 229476-53-3) EBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents.
- EPZ015666 (Catalog No# : 011309, Cas# : 1616391-65-1) EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 nM, >20,000-fold selectivity over other PMTs.
- EED226 (Catalog No# : 178311, Cas# : 2083627-02-3) EED226 is a potent, selective, and orally bioavailable EED inhibitor. induces robust and sustained tumor regression in EZH2MUT preclinical DLBCL model.
- Erdafitinib(JNJ-42756493) (Catalog No# : 651701, Cas# : 1346242-81-6) NEW Erdafitinib(JNJ-42756493) is a potent and selective panfibroblast growth factor receptor (FGFR 1, 2, 3 and 4)oral inhibitor.
- Ethyl 2-cyclohexyl-2-oxoacetate (Catalog No# : 178157, Cas# : 13275-31-5) Ethyl 2-cyclohexyl-2-oxoacetate
- E7449 (Catalog No# : 178903, Cas# : 1140964-99-3) E7449 is an orally available small molecule inhibitor of the nuclear enzymes poly (ADP-ribose) polymerase (PARP) 1 and 2, with potential antineoplastic activity.
- Elenbecestat(E2609) (Catalog No# : 2017878, Cas# : 1388149-30-1) NEW Elenbecestat,also known as E2609 is a BACE1 inhibitor.
- Etoposide Phosphate (Catalog No# : 20178213, Cas# : 117091-64-2) Etoposide phosphate is a phosphate salt of a semisynthetic derivative of podophyllotoxin.
Products Catalog
- Bioactive Small Molecules
-
- --- Cancer
- --- Infection
- --- Inflammation/Immunology
- --- Endocrinology /Metabolic
- --- Neurological Disease
- --- Stem Cells
- --- Other inhibitors
- Building blocks
-
- --- phenyl compounds
- --- Heterocyclic Compounds
- --- Boronic Acids
- --- Nitriles
- --- Other Building blocks